Methemoglobinemia

Revision as of 22:40, 23 September 2015 by Mholtz (talk | contribs)

Background

  • Methemoglobin refers to ferric form of Hb (Fe3+) that is unable to bind O2
  • Suspect in any patient with cyanosis not responsive to supplemental O2
  • Caused by exposure to oxidizing agent
    • Benzocaine
    • Dapsone
    • CN kit
    • Antimalarials

Clinical Features

  • Depends on level of metHb
    • Pts with anemia or preexisting cardiopulmonary disease will show symptoms sooner
    • <20%: asymptomatic, gray-blue cyanosis
    • 20-30%: anxiety, HA, weakness, light-headedness, tachycardia
    • 50-60%: myocardial ischemia, dysrhythmias, depressed mental status, seizure
    • >70%: usually fatal

Differential Diagnosis

Diagnosis

  • Co-oximetry
    • Measures relative levels of oxyhemoglobin, carboxyhemoglobin, methemoglobin, reduced hemoglobin
    • Usually performed on arterial blood sample, but fingertip CO-oximeter devices are available
  • SpO2 will initially be falsely elevated
    • Once MetHb >30% → SpO2 will fall to 80-85%
  • "Chocolate brown" color of blood

Management

  • Methylene Blue
    • Treat if symptomatic OR asymptomatic w/ MetHb >25%
    • 1-2mg/kg Methylene Blue IV over 5min; repeat dose if no effect
    • Improvement seen within 20min

See Also

References